Hematopoietic stem cell transplantation in thalassemia

Bone Marrow Transplantation
Javid GazievGuido Lucarelli

Abstract

SCT still remains the only cure currently available for patients with thalassemia. Results of transplants in this disease have steadily improved over the last two decades due to improvements in preventive strategies, effective control of transplant-related complications and development of new preparative regimens. Currently, high-resolution HLA typing has enabled physicians to perform transplants from unrelated volunteer donors for thalassemia with results comparable with those obtained employing an HLA-identical sibling. The probabilities for obtaining thalassemia-free survival after transplant in thalassemia from an HLA-identical donor, family member or MUD are between 85 and 87%. Therefore, when an HLA-identical donor is present, the transplant of allogeneic stem cell should be performed as allogeneic gene therapy. In the light of advances in transplantation for thalassemia, patients with an HLA-identical donor should be offered SCT.

Citations

May 14, 2009·Genome Medicine·David G Nathan, Stuart H Orkin
Jun 15, 2011·Expert Review of Hematology·Jacob Rozmus, Kirk R Schultz
Feb 26, 2013·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Maria Cristina ScerpaFrancesco Zinno
Nov 6, 2015·American Journal of Hematology·Deborah Rund
Jul 24, 2012·Best Practice & Research. Clinical Obstetrics & Gynaecology·Citra N MattarAmit C Nathwani
Jul 20, 2012·Best Practice & Research. Clinical Obstetrics & Gynaecology·Citra N MattarJerry K Y Chan
Jul 18, 2009·Clinical Biochemistry·Cornelis L HarteveldJoanne Traeger-Synodinos
Nov 1, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Parinda A Mehta, Lawrence B Faulkner
Jun 15, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jacob RozmusFrederick D Goldman
Dec 2, 2010·Blood·Mitchell SabloffMark C Walters
Feb 20, 2015·Hematology·Kim Smith-Whitley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.